Medical Secretaries often have training in medical terminology and, indeed AMSPAR (The Association of Medical Secretaries, Practice Managers, Administrators and Receptionists) offers professional qualifications in the subject area.
But entry into the patient record is just one part of the story. Patients sometimes see multiple consultants during their treatment and that can also mean time spent, looking back through pages of notes, either online or as paper records. It’s time-consuming and with time in short supply a number of organisations have seen an opportunity to get involved.
For every hour doctors spend with patients, they spend two hours on paperwork and note taking.
Healthcare is big business and not surprisingly, some of the biggest players in tech have thrown their hats into the ring in a bid to offer solutions that don't involve typing.
Just like in any sector, productivity is important and if doctors can reduce time in note-taking they can see more cases and, with better access to that data, provide better outcomes for their patients.
In November 2020, Google launched open source machine learning software to help doctors make sense of patient medical records. The platform is composed of two programs. One, an API for healthcare-related natural language processing, scans medical documents for key information about a patient’s journey, puts it into a standard format, and summarizes it for the doctor. It can pull from multiple sources of information like medical records as well as transcribed doctors’ notes. The goal is to create an easy way for doctors to review a patient’s past care.
The second, called AutoML Entity Extraction for Healthcare, is a low-code tool kit that helps doctors to pull out specific data from a patient’s record, like information about a genetic mutation.
Microsoft has Project EmpowerMD. EmpowerMD listens to clinical conversations between doctors and patients. It integrates this content with information from the patient's EHR and automatically generates a medical summary. This allows physicians to spend more face-to-face time with patients. EmpowerMD is a learning system built on Azure. It uses a rich set of machine learning (ML) algorithms to tackle complex natural language understanding challenges.
The system is highly customizable. Doctors can easily edit the summaries generated by the system to suit their own individual style. The system learns from all such interactions to achieve the best medical outcomes.
Amazon, the company that brought us Alexa, has also entered the fray. Amazon Transcribe Medical is an automatic speech recognition (ASR) service that makes it easy for doctors to add medical speech-to-text capabilities to voice-enabled applications.
Conversations between health care providers and patients provide the foundation of a patient’s diagnosis and treatment plan and clinical documentation workflow. It’s critically important that this information is accurate.
Driven by state-of-the-art machine learning, Amazon Transcribe Medical accurately transcribes medical terminologies such as medicine names, procedures, and even conditions or diseases. Amazon Transcribe Medical can serve a diverse range of use cases such as transcribing physician-patient conversations for clinical documentation, capturing phone calls in pharmacovigilance, or subtitling telehealth consultations.
Amazon Transcribe Medical is available as a set of public APIs that can address both batch workloads and real-time speech-to-text applications. The service prioritizes patient data privacy and security.
Amazon Transcribe Medical provides transcription expertise for primary care and specialty care areas such as cardiology, neurology, obstetrics-gynecology, pediatrics, oncology, radiology and urology.
Finally Nvidia, which has done a lot of work with AI and imaging, has started offering medical transcription. In 2020, Nvidia launched a service called BioMegatron, which is built to recognize conversational speech. The data set is trained on over six billion medical terms and is 92% accurate.
Good though these systems are - sometimes it still needs an experienced Med-Sec to ensure that the final record is accurate - fortunately Medmin has it covered...
The Stourside hospital in Stourbridge, run by Ramsay Health is an adjunct facility to a larger hospital nearby and offers an operating theatre with two recovery bays, an ambulatory unit with six pods , 7 OPD consulting rooms, a treatment room and mobile MRI and CT scanner. The facility is typical of the shift towards ambulatory care that started long before Covid but is considered to be a rapidly growing trend in healthcare investment.
In the USA, interest in the sector has been driven by lower costs for the payers - whether insured or self-pay but also by healthcare providers who can often achieve margins that are equal to or greater than those achieved in a full-blown hospital facility.
Of more than 3.4m jobs likely to be created in the healthcare and social assistance sector over the next 7 years, half will be in ambulatory care. Market research has indicated that in the five years between 2018 and 2023, Ambulatory Surgical Centres are projected to grow at 6% a year reaching $36 billion by the end of 2023 - staggering numbers.
A similar (proportional) increase in ambulatory care facilities can be expected in the UK - driven in part by consumer demand for lower costs - the USA has shown us that typical savings on a knee or hip replacement can be 30-40% but also a growing unease about the safety of hospitals in light of the covid pandemic - with both the private sector and NHS playing their part.
Another trend that we believe we should expect to see here are shared ownership models for these facilities with Surgeons and Clinical groups becoming equity owners of outside facilities, along with potentially new investors in healthcare.
Medmin’s clinic management model, along with the patient acquisition strategy that we have developed, are particularly suited to this style of healthcare - we are therefore extremely interested in seeing how this trend develops over the coming decade. It could be just the segmentation that the market desperately needs...
Private Medical insurance (PMI) has been on the decline since the 2008 recession.
Largely a workplace benefit, companies started withdrawing from PMI schemes as a cost-cutting exercise. The increase in Insurance Premium Tax from 5% in 2011 to 12% in 2017, alongside rising premiums made it less cost effective for both company and private PMI customers.
There has also been a systemic shift in attitudes around insurance between Boomers, Gen X and now Millennials. With access to cheap credit, many consumers prefer to pay as they go using a credit card or bank loan rather than monthly premiums.
It is perhaps not surprising then that 89% of the UK currently do not have Private medical Insurance.
Self-pay has always been part of the mix driven by rising PMI rates, increased waiting times for NHS treatment, procedures not being covered at all by the NHS and an increasing market for aesthetic and cosmetic surgery.
Prior to 2020, Self-pay was growing at about 6% a year and the total value of the self-pay market for private treatments was £1.8bn. We had been seeing a rising interest in those areas where waiting lists were long and procedures cost below £7000.
Covid has been a game changer.
What Covid has taught us is that health matters and people are prepared to pay for it. There has been a bump in PMI but by far the biggest jump has been in self-pay.
Self-pay is booming and the rate of demand is increasing month by month.
As a consequence of the COVID crisis NHS waiting times have dramatically increased and will continue to do so. The NHS is currently reviewing all patients on waiting lists to determine if they still wish to be treated and also restricting access to a growing list of specific procedures.
Patients fear going to an NHS hospital where COVID patients will also be treated.
Research in 2017 for BMI Healthcare found that over 53% of people had not heard of or did not understand the concept of self-pay. Keith Pollard Editor in Chief of The International Medical Travel Journal wrote in June 2019 “There’s a vast untapped market out there of middle-income consumers who can’t afford health insurance and don’t access private healthcare – they don’t understand it and they think they can’t afford it.”
The reduction in NHS capacity combined with a permanent increase in people’s personal savings habits provides an exciting opportunity to stimulate patients’ interest in self-pay healthcare services.
Medmin are taking on the challenge!
We have already seen that Telehealth has been catapulted from zero to hero in a matter of weeks following the first lockdown in 2020, but virtual health is more than a video consultation with your GP.
We are defining virtual health across three categories—telehealth, digital therapeutics, and care navigation - these are defined in the chart below (helpfully published by McKinsey).
Care navigation is of particular interest (to us) as it may form the basis of how patients choose their treatment.
econsult was set up by a group of GPs in the UK and has been adopted by over 3000 NHS GP surgeries. eConsult is a form-based online consultation platform that collects your medical or administrative request and sends it through to your GP practice to triage and decide on the right care for you and everyone else.
ePAQ is an electronic questionnaire that patients can use to improve diagnosis and outcomes by aiding the communication process between patient and consultant.
Developed by a consultant Gynaecologist and IT professionals ePAQ has combined the accuracy and reliability of validated self-completed patient friendly questionnaires with intelligent computer software analysis and reporting.
The conditions it deals with are particularly difficult for some patients to discuss and it has been shown to be more effective in allowing patients to describe the problems they are facing.
Apple has entered the Health space quite aggressively with the watch an integral part . Owners of the watch right back to series 1 can set it to alert if it detects atrial fibrillation with an alert to contact a physician should it detect irregularities.
The later models can take heart readings and via an ECG app share those results with a doctor. Apple Health is also moving towards storing clinical data so all your procedures, vaccinations, lab results, medications and more will live in the app.
Perhaps the best indication though that virtual health is really on the move is the fact that investment is pouring into the sector. K Health in the USA uses machine learning to lower the cost of care by providing the bulk of the company's health assessments. - it raised $222 million in 2020 from investors interested in its model of being a virtual primary care provider.
The internet made video calling a relatively straightforward proposition but the take-up had been slow - until Covid. The reluctance of GPs to have patients at their surgeries, along with a similar reluctance on the part of patients visiting those surgeries made Telehealth an obvious answer.
Ten years of change happened in one week of lockdown Covid provided a tipping point. Across the US alone, nearly half of healthcare consumers are now using telehealth, according to consultancy firm McKinsey—up from one in 10 last year. In Europe, virtual medicine has been held back by strict privacy regulations and patients reluctant to give up in-person doctor’s visits. British primary care doctors, too, have been barraged by growing workloads of late, with patients living longer and more problems being rerouted from hospitals, leaving them little time to train on virtual tools.
Technology companies are racing to capitalise on a regulatory pullback by governments as they battle the virus. Local GPs, many of them once skeptics, are rushing into the new age, too, singing the praises of virtual visits that they say save them time and offer a useful complement to physical exams. Before the virus, video appointments made up only 1 percent of the 340 million or so annual visits to primary care doctors and nurses in Britain’s National Health Service.
The NHS told thousands of clinics across the country to start switching to remote consultations lin April and said it had fast-tracked approval of digital providers to ramp up their offerings. Push Doctor, a telemedicine company, said its weekly orders had grown 70 percent since the outbreak. Docly, another company, said demand had increased by 100 percent from one week to the next as the virus spread. The shift is striking in Britain, where regulatory hurdles and a cluttered bureaucracy have left telemedicine companies complaining for years about access.
Many doctors attributed the mass adoption of remote appointments to a company called accuRx. Already a trusted tool for doctors who wanted to send text messages to patients, accuRx built a video-calling system over a weekend after the virus hit Britain. It quickly became the go-to provider for online appointments, offering a stripped-down interface and the comfort of having long been in primary care clinics. More than 90 percent of primary care clinics in England are now using it. Doctors said patients had seemed to adapt quickly, with the help of occasional coaching in how to open text messages and video links. What is clear however is that there is no going back - telehealth is here to stay and not just in primary care.
Here at Medmin - many of our surgeons have been undertaking initial consultations with patients over telephone or video call while covid has been rife. For some patients, particularly with conditions that they find embarrassing or difficult to discuss, there have been clear benefits, for others there has been a lessening in anxiety about visiting a consulting room in a hospital. For doctors who have been asymptomatic but tested positive for Covid, they have been able to continue making a contribution by seeing patients while sequestered at home